Toll Free: 1-888-928-9744

Selvita S.A. - Product Pipeline Review - 2016

Published: Feb, 2016 | Pages: 41 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Selvita S.A. - Product Pipeline Review - 2016

Summary
Global Markets Direct's, 'Selvita S.A. - Product Pipeline Review - 2016', provides an overview of the Selvita S.A.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Selvita S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Selvita S.A. - The report provides overview of Selvita S.A. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Selvita S.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Selvita S.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Selvita S.A.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Selvita S.A. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Selvita S.A.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Selvita S.A. Snapshot 5 Selvita S.A. Overview 5 Key Information 5 Key Facts 5 Selvita S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Selvita S.A. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Selvita S.A. - Pipeline Products Glance 12 Selvita S.A. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Selvita S.A. - Drug Profiles 14 SEL-120 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 SEL-12034 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 SEL-201 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 SEL-24 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 SEL-24A1 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 SEL-24B489 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 SEL-300 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 SLV-2436 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecules to Inhibit Kinase for Oncology 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SEL-128 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 SEL-212 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 SEL-303 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Small Molecules for Oncology 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecules for Solid Tumors and Hematological Malignancies 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Selvita S.A. - Pipeline Analysis 32 Selvita S.A. - Pipeline Products by Target 32 Selvita S.A. - Pipeline Products by Route of Administration 33 Selvita S.A. - Pipeline Products by Molecule Type 34 Selvita S.A. - Pipeline Products by Mechanism of Action 35 Selvita S.A. - Recent Pipeline Updates 36 Selvita S.A. - Dormant Projects 37 Selvita S.A. - Discontinued Pipeline Products 38 Discontinued Pipeline Product Profiles 38 SEL-113 38 Selvita S.A. - Locations and Subsidiaries 39 Head Office 39 Other Locations & Subsidiaries 39 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 40 Disclaimer 41
List of Tables
Selvita S.A., Key Information 5 Selvita S.A., Key Facts 5 Selvita S.A. - Pipeline by Indication, 2016 8 Selvita S.A. - Pipeline by Stage of Development, 2016 10 Selvita S.A. - Monotherapy Products in Pipeline, 2016 11 Selvita S.A. - Preclinical, 2016 12 Selvita S.A. - Discovery, 2016 13 Selvita S.A. - Pipeline by Target, 2016 32 Selvita S.A. - Pipeline by Route of Administration, 2016 33 Selvita S.A. - Pipeline by Molecule Type, 2016 34 Selvita S.A. - Pipeline Products by Mechanism of Action, 2016 35 Selvita S.A. - Recent Pipeline Updates, 2016 36 Selvita S.A. - Dormant Developmental Projects,2016 37 Selvita S.A. - Discontinued Pipeline Products, 2016 38 Selvita S.A., Subsidiaries 39



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify